Skip to main content
. 2009 Oct 17;25(4):873–881. doi: 10.1359/jbmr.091027

Table 3.

Fracture Incidence and Fall Frequency by Use of AEDs at Baseline

Number of Events Annual % Model 1a HRc (95% CI) Model 2b HRc (95% CI)
Hip fractures
 Nonuser 1,532 0.15 1.00 1.00
 User 30 0.29 1.98 (1.38–2.85) 1.51 (1.05–2.17)
  <2 years 10 0.30 2.19 (1.18–4.08) 1.59 (0.85–2.97)
  2 to 5 years 9 0.27 1.72 (0.89–3.32) 1.31 (0.68–2.53)
  >5 years 11 0.31 2.07 (1.14–3.74) 1.63 (0.90–2.95)
Clinical vertebral fractures
  Nonuser 2,355 0.22 1.00 1.00
  User 49 0.48 2.15 (1.62–2.86) 1.60 (1.20–2.12)
  <2 years 17 0.51 2.38 (1.48–3.84) 1.69 (1.05–2.73)
  2 to 5 years 12 0.37 1.61 (0.91–2.85) 1.17 (0.66–2.07)
  >5 years 20 0.56 2.45 (1.58–3.80) 1.92 (1.23–2.98)
Lower arm or wrist
 Nonuser 5,034 0.48 1.00 1.00
 User 74 0.72 1.52 (1.21–1.91) 1.40 (1.11–1.76)
  <2 years 15 0.45 0.95 (0.57–1.58) 0.90 (0.54–1.49)
  2 to 5 years 28 0.83 1.79 (1.23–2.60) 1.64 (1.13–2.38)
  >5 years 31 0.87 1.79 (1.26–2.55) 1.63 (1.14–2.32)
Other clinical fractures
 Nonuser 15,974 1.51 1.00 1.00
 User 256 2.49 1.73 (1.53–1.96) 1.46 (1.29–1.65)
  <2 years 86 2.56 1.76 (1.42–2.17) 1.48 (1.19–1.83)
  2 to 5 years 71 2.11 1.44 (1.14–1.82) 1.21 (0.96–1.53)
  >5 years 99 2.79 1.99 (1.63–2.42) 1.69 (1.38–2.06)
Total fractures
 Nonuser 22,137 2.10 1.00 1.00
 User 344 3.35 1.70 (1.53–1.89) 1.44 (1.30–1.61)
  <2 years 107 3.18 1.60 (1.32–1.93) 1.36 (1.12–1.64)
  2 to 5 years 103 3.06 1.53 (1.26–1.85) 1.29 (1.07–1.57)
  >5 years 134 3.78 1.96 (1.66–2.33) 1.68 (1.42–1.99)
Two or more falls
 Nonuser 45,246 4.29 1.00 1.00
 User 760 7.40 2.15 (2.00–2.31) 1.62 (1.50–1.74)
  <2 years 257 7.65 2.23 (1.97–2.52) 1.58 (1.40–1.79)
  2 to 5 years 239 7.10 2.05 (1.80–2.33) 1.55 (1.36–1.76)
  >5 years 264 7.44 2.16 (1.92–2.44) 1.71 (1.52–1.94)
a

Model 1 adjusted for age, ethnicity, BMI, and WHI trial participation and intervention.

b

Model 2 adjusted for age, race/ethnicity, BMI, smoking, alcohol, calcium and vitamin D intake, history of fractures (fracture at age 55+), history of falls (two or more in the year prior to enrollment), bisphosphonates, past/current use of HT, SERMs, calcitonin, age of menopause, physical activity levels, physical function construct, diabetes, stroke, parental history of hip fractures, study site region, self-reported health, multiple sclerosis, Parkinson's, WHI trial participation and intervention.

bc Nonusers of AEDs are the reference group for both the any-use and the duration models.